ALS Today is an independent interactive news magazine featuring the latest research advances and potential therapies for ALS/MND. Published by ALS TDI, ALS Today informs clinicians, research scientists, patients and care providers about global efforts to end ALS. Find us online www.als.net/ALSToday. Follow us on Twitter @ALSToday.
Paul Gordon MD of the Indian Health Service (HIS) talks about his latest results which suggest that ALS might be less common in Native Americans. His ...
Steve Vucic PhD of Neuroscience Research Australia talks about transcranial magnetic stimulation (TMS), an emerging test that may help clinicians iden...
Kirsten Gruis MD of the State University of New York talks about the NeuRX DPS, a device that aims to help people with ALS breathe better and live lon...
Pierre-Francois Pradat MD PhD of the Assistance Publique - Hôpitaux de Paris in France talks about GSK's potential ALS medicine ozanezumab, now at pha...
Steve Perrin PhD, CEO and CSO of ALS TDI, talks Gilenya, other emerging immunomodulators and their potential to treat ALS going forward. Read more: ht...
Michael Weiss MD, Director of the Neuromuscular Diseases Division of the University of Washington School of Medicine, discusses an upcoming phase II c...
Doug Kerr MD PhD, Biogen-Idec’s Director of Neurodegenerative Research, talks dexpramipexole, the lessons learned and the development of future ALS me...
Robert Miller MD, Director of California Pacific Medical Center’s Forbes Norris MDA/ALS Research and Treatment Center, talks NP001 and its potential t...
Athanase Millogo, MD of Bobo-Dioulasso University Teaching Hospital in Burkina Faso, talks TROPALS and its potential impact on people with ALS/MND in ...
Jeff Rothstein MD PhD, director of the Packard Center for ALS Research at Johns Hopkins University School of Medicine, talks C9ORF72 and potential tre...